Počet záznamů: 1
Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid
SYS 0533415 LBL 01000a^^22220027750^450 005 20240103224601.2 014 $a 85083503647 $2 SCOPUS 014 $a 32152203 $2 PUBMED 014 $a 000551370100038 $2 WOS 017 70
$a 10.1158/1078-0432.CCR-19-2335 $2 DOI 100 $a 20201023d m y slo 03 ba 101 0-
$a eng 102 $a US 200 1-
$a Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid 215 $a 13 s. 463 -1
$1 001 cav_un_epca*0252466 $1 011 $a 1078-0432 $e 1557-3265 $1 200 1 $a Clinical Cancer Research $v Roč. 26, č. 14 (2020), s. 3868-3880 $1 210 $c American Association for Cancer Research 608 $a Article 610 $a succinate-dehydrogenase 610 $a complex-ii 610 $a inhibitor sunitinib 610 $a hydrogen-peroxide 700 -1
$3 cav_un_auth*0278262 $a Liu $b Y. $y US 701 -1
$3 cav_un_auth*0363231 $a Pang $b Y. $y US 701 -1
$3 cav_un_auth*0397926 $4 070 $a Zhu $b B. $y US 701 -1
$3 cav_un_auth*0397927 $4 070 $a Uher $b O. $y US 701 -1
$3 cav_un_auth*0363229 $4 070 $a Caisova $b V. $y US 701 -1
$3 cav_un_auth*0397928 $4 070 $a Huynh $b T.-T. $y US 701 -1
$3 cav_un_auth*0375531 $4 070 $a Taieb $b D. $y FR 701 -1
$3 cav_un_auth*0397929 $4 070 $a Váňová-Hadrava $b Kateřina $p BTO-N $i Laboratoř molekulární terapie $y CZ $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0397930 $4 070 $a Ghayee $b H. K. $y US 701 -1
$3 cav_un_auth*0239896 $a Neužil $b Jiří $p BTO-N $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $y CZ $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0397931 $4 070 $a Levine $b M. $y US 701 -1
$3 cav_un_auth*0271589 $a Yang $b Ch. $y US 701 -1
$3 cav_un_auth*0346159 $a Pacak $b K. $y US 856 $9 RIV $u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443979/
Počet záznamů: 1